Aldosterone- and cortisol-co-secreting adrenal tumors: The lost subtype of primary aldosteronism

European Journal of Endocrinology

Volumn 164, Issue 4, 2011, Pages 447-455

  Späth, Martin ^a   Korovkin, Svetlana ^a   Antke, Christiane ^a   Anlauf, Martin ^a   Willenberg, Holger S ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXYHYDROCORTISONE; ALDOSTERONE; ALDOSTERONE SYNTHASE; CAPTOPRIL; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOCHROME P450 17; DESMOPRESSIN; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; PRASTERONE SULFATE; STEROID 11BETA MONOOXYGENASE; STEROID 17ALPHA MONOOXYGENASE;

ADRENAL HYPERPLASIA; ADRENAL TUMOR; ADRENALECTOMY; CUSHING SYNDROME; ELECTROLYTE DISTURBANCE; HISTOPATHOLOGY; HUMAN; HYPERCORTISOLISM; HYPERTENSION; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PREOPERATIVE EVALUATION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SYSTEMATIC REVIEW; TUMOR VOLUME; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX INSUFFICIENCY; ALDOSTERONE RELEASE; CLINICAL FEATURE; DEXAMETHASONE SUPPRESSION TEST; HYDROCORTISONE RELEASE; LABORATORY DIAGNOSIS; SUBSTITUTION THERAPY; TUMOR CLASSIFICATION;

ADRENAL GLAND NEOPLASMS; ALDOSTERONE; ANIMALS; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM;

EID: 79953228533     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1070     Document Type: Review

References (83)

1. Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. Journal of Laboratory and Clinical Medicine 1955 45 3-17.
2. Sutherland DJ, Ruse JL & Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Canadian Medical Association Journal 1966 95 1109-1119.
3. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL & Krek AL. Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clinical and Experimental Pharmacology and Physiology 1991 18 283-286. (doi:10.1111/j.1440-1681.1991.tb01446.x)
4. Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M & Lifton RP. A novel form of human mendelian hypertension featuring nonglucocorticoid- remediable aldosteronism. Journal of Clinical Endocrinology and Metabolism 2008 93 3117-3123. (doi:10.1210/jc.2008-0594)
5. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S & Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992 355 262-265. (doi:10.1038/355262a0)
6. Torpy DJ, Gordon RD, Lin JP, Huggard PR, Taymans SE, Stowasser M, Chrousos GP & Stratakis CA. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. Journal of Clinical Endocrinology and Metabolism 1998 83 3214-3218. (doi:10.1210/jc.83.9.3214)
7. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr & Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 3266-3281. (doi:10.1210/jc.2008-0104)
8. Reincke M, Beuschlein F, Bidlingmaier M, Funder JW & Bornstein SR. Progress in primary aldosteronism. Hormone and Metabolic Research 2010 42 371-373. (doi:10.1055/s-0030-1253417)
9. Auchus RJ, Wians FH Jr, Anderson ME, Dolmatch BL, Trimmer CK, Josephs SC, Chan D, Toomay S & Nwariaku FE.What we still do not know about adrenal vein sampling for primary aldosteronism. Hormone and Metabolic Research 2010 42 411-415. (doi:10.1055/s-0030-1252060)
10. Stewart PM & Allolio B. Adrenal vein sampling for primary aldosteronism: time for a reality check. Clinical Endocrinology 2010 72 146-148. (doi:10.1111/j.1365-2265.2009.03714.x)
11. Gomez-Sanchez CE, Rossi GP, Fallo F & Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Hormone and Metabolic Research 2010 42 374-381. (doi:10.1055/s-0029-1243619)
12. Adachi J, Hirai Y, Terui K, Nakano T, Fukuda Y, Suda T & Sasano H. A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Internal Medicine 2003 42 714-718. (doi:10.2169/internalmedicine.42.714)
13. Willenberg HS, Spath M, Maser-Gluth C, Engers R, Anlauf M, Dekomien G, Schott M, Schinner S, Cupisti K & Scherbaum WA. Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism. Hypertension Research 2010 33 467-472. (doi:10.1038/hr.2010.18)
14. Allan CA, Kaltsas G, Perry L, Lowe DG, Reznek R, Carmichael D & Monson JP. Concurrent secretion of aldosterone and cortisol from an adrenal adenoma - value of MRI in diagnosis. Clinical Endocrinology 2000 53 749-753. (doi:10.1046/j.1365-2265.2000.01022.x)
15. Baert D, Nobels F & Van Crombrugge P. Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma. Acta Clinica Belgica 1995 50 310-313.
16. Fujii H, Kamide K, Miyake O, Abe T, Nagai M, Nakahama H, Horio T, Takiuchi S, Okuyama A, Yutani C & Kawano Y. Primary aldosteronism combined with preclinical Cushing's syndrome in an elderly patient. Circulation Journal 2005 69 1425-1427. (doi:10.1253/circj.69.1425)
17. Guthrie GP Jr & Kotchen TA. Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma. American Journal of Medicine 1979 67 524-528. (doi:10.1016/0002- 9343(79)90805-2)
18. Hobma S, Hermus A, Pieters G, Smals A & Kloppenborg P. Concurrent hypercortisolism and hyperaldosteronism due to an adrenal adenoma. Klinische Wochenschrift 1990 68 981-983. (doi:10.1007/BF01646658)
19. Hogan MJ, Schambelan M & Biglieri EG. Concurrent hypercortisolism and hypermineralocorticoidism. American Journal of Medicine 1977 62 777-782. (doi:10.1016/0002-9343(77)90883-X)
20. Honda T, Nakamura T, Saito Y, Ohyama Y, Sumino H & Kurabayashi M. Combined primary aldosteronism and preclinical Cushing's syndrome: an unusual case presentation of adrenal adenoma. Hypertension Research 2001 24 723-726. (doi:10.1291/hypres.24.723)
21. Imai T, Seo H, Murata Y, Funahashi H, Satoh Y, Sasano H, Matsui N & Takagi H. Dexamethasone-nonsuppressible cortisol in two cases with aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism 1991 72 575-581. (doi:10.1210/jcem-72-3-575)
22. Komiya I, Koizumi Y, Kobayashi R, Kotani M, Yamada T & Maruyama Y. Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma. American Journal of Medicine 1979 67 516-518. (doi:10.1016/0002- 9343(79)90803-9)
23. Makino S, Oda S, Saka T, Yasukawa M, Komatsu F & Sasano H. A case of aldosterone-producing adrenocortical adenoma associated with preclinical Cushing's syndrome and hypersecretion of parathyroid hormone. Endocrine Journal 2001 48 103-111. (doi:10.1507/endocrj.48.103)
24. Markou A, Tsigou K, Papadogias D, Kossyvakis K, Vamvakidis K, Kounadi T & Piaditis G. A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor. Hormones 2005 4 226-230.
25. Nagae A, Murakami E, Hiwada K, Kubota O, Takada Y & Ohmori T. Primary aldosteronism with cortisol overproduction from bilateral multiple adrenal adenomas. Japanese Journal of Medicine 1991 30 26-31.
26. Oki K, Yamane K, Sakashita Y, Kamei N, Watanabe H, Toyota N, Shigeta M, Sasano H & Kohno N. Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas. Clinical and Experimental Nephrology 2008 12 382-387. (doi:10.1007/s10157-008-0064-3)
27. Okura T, Miyoshi K, Watanabe S, Kurata M, Irita J, Manabe S, Fukuoka T, Higaki J & Sasano H. Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushing's syndrome. Clinical and Experimental Nephrology 2006 10 127-130. (doi:10.1007/s10157-006-0413-z)
28. Onoda N, Ishikawa T, Nishio K, Tahara H, Inaba M, Wakasa K, Sumi T, Yamazaki T, Shigematsu K & Hirakawa K. Cushing's syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: report of a case. Endocrine Journal 2009 56 495-502. (doi:10.1507/endocrj.K08E-268)
29. Rossi E, Foroni M, Regolisti G, Perazzoli F, Negro A, Santi R, Grasselli C, Galli P & Gardini G. Combined Conn's syndrome and subclinical hypercortisolism from an adrenal adenoma associated with homolateral renal carcinoma. American Journal of Hypertension 2008 21 1269-1272. (doi:10.1038/ajh.2008.259)
30. Saito T, Ikoma A, Saito T, Tamemoto H, Suminaga Y, Yamada S, Kawakami M, Suzuki T, Sasano H & Ishikawa SE. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland. Endocrine Journal 2007 54 287-293. (doi:10.1507/endocrj.K06-180)
31. Sasaki N, Iwase M, Arima H, Nohara S, Bandai S, Yao T, Fujii K & Iida M. Overt diabetes mellitus in a patient with combined primary aldosteronism and Cushing's syndrome. Internal Medicine 2006 45 1237-1242. (doi:10.2169/ internalmedicine.45.1855)
32. Sugawara A, Takeuchi K, Suzuki T, Itoi K, Sasano H & Ito S. A case of aldosterone-producing adrenocortical adenoma associated with a probable post-operative adrenal crisis: histopathological analyses of the adrenal gland. Hypertension Research 2003 26 663-668. (doi:10.1291/hypres.26.663)
33. Suzuki J, Otsuka F, Inagaki K, Otani H, Miyoshi T, Terasaka T, Ogura T, Omori M, Nasu Y & Makino H. Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion. Hypertension Research 2007 30 367-373. (doi:10.1291/hypres.30.367)
34. Tanaka M, Izeki M, Miyazaki Y, Horigome M, Yoneda T, Tsuyuki S, Takami S & Aiba M. Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated by Hashimoto's thyroiditis. Internal Medicine 2002 41 967-971. (doi:10.2169/internalmedicine.41.967)
35. Tsunoda K, Abe K, Yamada M, Kato T, Yaoita H, Taguma Y, Goto Y & Ioridani N. A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing's syndrome. Hypertension Research 2008 31 1669-1675. (doi:10.1291/hypres.31.1669)
36. Tunny TJ, Klemm SA & Gordon RD. Some aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism. Clinical and Experimental Pharmacology and Physiology 1990 17 167-171. (doi:10.1111/j.1440-1681.1990.tb01300.x)
37. Yamakita N, Murai T, Miyamoto K, Matsunami H, Ikeda T, Sasano H, Mune T & Yasuda K. Variant of pre-clinical Cushing's syndrome: hypertension and hypokalemia associated with normoreninemic normoaldosteronism. Hypertension Research 2002 25 623-630. (doi:10.1291/hypres.25.623)
38. Sakai N, Yamada T, Asao T & Murayama T. Aldosterone-producing adrenocortical carcinoma metastases found seven years after adrenalectomy. International Journal of Urology 1997 4 79-82. (doi:10.1111/j.1442-2042.1997. tb00145.x)
39. Ali AE & Raphael SJ. Functional oncocytic adrenocortical carcinoma. Endocrine Pathology 2007 18 187-189. (doi:10.1007/s12022-007-9000-4)
40. Abma EM, Kluin PM & Dullaart RP. Malignant aldosterone-producing adrenal tumour: reoccurrence with glucocorticoid excess without hyperaldosteronism. Netherlands Journal of Medicine 2008 66 252-255. (Pubitemid 351935811)
41. Alterman SL, Dominguez C, Lopez-Gomez A & Lieber AL. Primary adrenocortical carcinoma causing aldosteronism. Cancer 1969 24 602-609. (doi:10.1002/1097-0142(196909)24:3〈602::AID-CNCR2820240327〉3.0.CO;2-2)
42. Arteaga E, Biglieri EG, Kater CE, Lopez JM & Schambelan M. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Annals of Internal Medicine 1984 101 316-321.
43. Barzon L, Masi G, Fincati K, Pacenti M, Pezzi V, Altavilla G, Fallo F & Palu G. Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma. European Journal of Endocrinology 2005 153 629-636. (doi:10.1530/eje.1.02011)
44. Brooks RV, Mc SR, Prunty FT & Wood FJ. Potassium deficiency of renal and adrenal origin. American Journal of Medicine 1957 23 391-407. (doi:10.1016/0002-9343(57)90319-4)
45. Crane MG, Harris JJ & Herber R. Primary aldosteronism due to an adrenal carcinoma. Annals of Internal Medicine 1965 63 494-503.
46. Deckers S, Derdelinckx L, Col V, Hamels J & Maiter D. Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism. Hormone Research 1999 52 97-100. (doi:10.1159/000023442)
47. Farge D, Chatellier G, Pagny JY, Jeunemaitre X, Plouin PF & Corvol P. Isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma. American Journal of Medicine 1987 83 635-640. (doi:10.1016/0002-9343(87)90891-6)
48. Feller N, Hoekman K, Kuiper CM, Linn SC, Verheul HM, Wolthers BG, Popp-Snijders C & Pinedo HM. A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile. Clinical Cancer Research 1997 3 389-394. (Pubitemid 27158062)
49. Foye LV Jr & Feichtmeir TV. Adrenal cortical carcinoma producing solely mineralocorticoid effect. American Journal of Medicine 1955 19 966-975. (doi:10.1016/0002-9343(55)90163-7)
50. Hisamatsu H, Sakai H, Irie J, Maeda K & Kanetake H. Adrenocortical carcinoma with primary aldosteronism associated with Cushing syndrome during recurrence. BJU International 2002 90 971-972. (doi:10.1046/j.1464-410X.2002. 02937.x)
51. Jackson WP, Zilberg B, Lewis B & Mc KD. Cushing's syndrome in childhood; report of case of adrenocortical carcinoma with excessive aldosterone production. BMJ 1958 2 130-133. (doi:10.1136/bmj.2.5089.130)
52. Kurtulmus N, Yarman S, Azizlerli H & Kapran Y. Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. Hormone Research 2004 62 67-70. (doi:10.1159/000079322)
53. Messer CK, Kirschenbaum A, New MI, Unger P, Gabrilove JL & Levine AC. Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature. Endocrine Practice 2007 13 408-412.
54. Peppa M, Pikounis V, Papaxoinis G, Macheras A, Economopoulos T, Raptis SA & Hadjidakis D. Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: a case report. Cases Journal 2009 2 8951. (doi:10.4076/1757-1626-2- 8951)
55. Salassa TM, Weeks RE, Northcutt RC & Carney JA. Primary aldosteronism and malignant adrenocortical neoplasia. Transactions of the American Clinical and Climatological Association 1975 86 163-172.
56. Weingartner K, Gerharz EW, Bittinger A, Rosai J, Leppek R & Riedmiller H. Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma. Case report and review of the literature. Urologia Internationalis 1995 55 232-235. (doi:10.1159/000282795)
57. Sone M, Shibata H, Homma K, Tamura N, Akahira J, Hamada S, Yahata M, Fukui N, Itoh H, Sasano H & Nakao K. Close examination of steroidogenesis disorders in a DOC- and progesterone-producing adrenocortical carcinoma. Endocrine 2009 35 25-33. (doi:10.1007/s12020-008-9123-5)
58. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
59. Willenberg HS, Kolentini C, Quinkler M, Cupisti K, Krausch M, Schott M & Scherbaum WA. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism. European Journal of Clinical Investigation 2009 39 43-50. (doi:10.1111/j.1365- 2362.2008.02060.x)
60. Balas M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA & Willenberg HS. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism. Hypertension Research 2010 33 850-856. (doi:10.1038/hr.2010.76)
61. Born-Frontsberg E, Reincke M, Beuschlein F & Quinkler M. Tumor size of Conn's adenoma and comorbidities. Hormone and Metabolic Research 2009 41 785-788. (doi:10.1055/s-0029-1224200)
62. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H & Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Archives of Internal Medicine 1981 141 1589-1593. (doi:10.1001/archinte.141.12. 1589)
63. Hayashi Y, Takeda Y, Kaneko K, Koyama H, Aiba M, Ikeda U & Shimada K. A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids. Endocrine Journal 1998 45 485-491. (doi:10.1507/endocrj.45.485)
64. Mazzuco TL, Grunenwald S, Lampron A, Bourdeau I & Lacroix A. Aberrant hormone receptors in primary aldosteronism. Hormone and Metabolic Research 2010 42 416-423. (doi:10.1055/s-0029-1243602)
65. Stowasser M, Tunny TJ, Klemm SA & Gordon RD. Cortisol production by aldosterone-producing adenomas in vitro. Clinical and Experimental Pharmacology and Physiology 1993 20 292-295. (doi:10.1111/j.1440-1681.1993.tb01686.x)
66. Stowasser M, Bachmann AW, Tunny TJ & Gordon RD. Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clinical and Experimental Pharmacology and Physiology 1996 23 591-593. (doi:10.1111/j.1440-1681.1996. tb02789.x)
67. Gordon RD. Primary aldosteronism. Journal of Endocrinological Investigation 1995 18 495-511.
68. Freel EM, Shakerdi LA, Friel EC, Wallace AM, Davies E, Fraser R & Connell JM. Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects. Journal of Clinical Endocrinology and Metabolism 2004 89 4628-4633. (doi:10.1210/jc.2004-0379)
69. Bogdan A, Auzeby A, Plouin PF & Touitou Y. In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn's adenoma tissues. Journal of Endocrinological Investigation 1993 16 65-68.
70. Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI & White PC. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. PNAS 1992 89 8327-8331. (doi:10.1073/pnas.89.17.8327)
71. Mosso L, Gomez-Sanchez CE, Foecking MF & Fardella C. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension 2001 38 688-691.
72. Reznek RH & Armstrong P. The adrenal gland. Clinical Endocrinology 1994 40 561-576. (doi:10.1111/j.1365-2265.1994.tb03006.x)
73. Shigematsu K, Nishida N, Sakai H, Igawa T, Suzuki S, Kawai K & Takahara O. Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman. Endocrine Pathology 2009 20 66-72. (doi:10.1007/s12022-009-9060-8)
74. Neville AM & O'Hare MJ. Histopathology of the human adrenal cortex. Clinics in Endocrinology and Metabolism 1985 14 791-820. (doi:10.1016/S0300- 595X(85)80078-5)
75. Ganguly A. Cellular origin of aldosteronomas. Clinical Investigator 1992 70 392-395. (doi:10.1007/BF00235519)
76. Reincke M, Beuschlein F, Menig G, Hofmockel G, Arlt W, Lehmann R, Karl M & Allolio B. Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. Journal of Endocrinology 1998 156 415-423. (doi:10.1677/joe.0.1560415)
77. Glaz E, Racz K, Varga I, Kiss R, Sergev O, Futo L, Szecseny A & Schaff Z. Atrial natriuretic peptide directly inhibits corticosteroid biosynthesis in human aldosterone-producing adenoma. Acta Medica Hungarica 1988 45 377-386. (Pubitemid 19086575)
78. Racz K, Feher J, Csomos G, Varga I, Kiss R & Glaz E. An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells. Journal of Endocrinology 1990 124 341-345. (doi:10.1677/joe.0.1240341)
79. Wolf A, Willenberg HS, Cupisti K, Schott M, Geddert H, Raffel A, Bornstein SR, Scherbaum WA & Knoefel WT. Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnostic and therapeutic management. Hormone and Metabolic Research 2005 37 391-395. (doi:10.1055/s-2005- 870159)
80. Weiss LM, Medeiros LJ & Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. American Journal of Surgical Pathology 1989 13 202-206. (doi:10.1097/00000478-198903000-00004)
81. Suzuki H, Shibata H, Maruyama T, Ishimura Y & Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids 1995 60 42-47. (doi:10.1016/0039- 128X(94)00025-8)
82. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC & Mantero F. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. Journal of the American College of Cardiology 2006 48 2293-2300. (doi:10.1016/j.jacc.2006.07.059)
83. Quinkler M, Born-Frontsberg E & Fourkiotis VG. Comorbidities in primary aldosteronism. Hormone and Metabolic Research 2010 42 429-434. (doi:10.1055/s-0029-1243257)